OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence and Clinical Aspects of Mild Cognitive Impairment in Parkinson's Disease: A Meta‐Analysis
Chiara Baiano, Paolo Barone, Luigi Trojano, et al.
Movement Disorders (2019) Vol. 35, Iss. 1, pp. 45-54
Closed Access | Times Cited: 241

Showing 26-50 of 241 citing articles:

Effects of Transcranial Direct Current Stimulation on Potential P300-Related Events and Alpha and Beta EEG Band Rhythms in Parkinson's Disease
Rosa Angela Fabio, Rossella Suriano, Antonio Gangemi
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 2, pp. 25-25
Open Access | Times Cited: 6

Are the criteria for PD-MCI diagnosis comprehensive? A Machine Learning study with modified criteria
Chiara Longo, Daniele Romano, Maria Pennacchio, et al.
Parkinsonism & Related Disorders (2024) Vol. 124, pp. 106987-106987
Closed Access | Times Cited: 6

Cross-sectional associations between cognition and mobility in Parkinson’s disease
Nariana Mattos Figueiredo Sousa, Roberta Corrêa Macedo, Sônia Maria Dozzi Brucki
Dementia & Neuropsychologia (2021) Vol. 15, Iss. 1, pp. 105-111
Open Access | Times Cited: 38

Morphological basis of Parkinson disease-associated cognitive impairment: an update
K. A. Jellinger
Journal of Neural Transmission (2022) Vol. 129, Iss. 8, pp. 977-999
Closed Access | Times Cited: 26

Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson’s Disease Psychosis: Systematic Review and Network Meta-Analysis
Ismaeel Yunusa, Nazia Rashid, Roxanna Seyedin, et al.
Journal of Geriatric Psychiatry and Neurology (2023) Vol. 36, Iss. 5, pp. 417-432
Closed Access | Times Cited: 15

Spontaneous brain activity in the hippocampal regions could characterize cognitive impairment in patients with Parkinson's disease
Peng Chen, Guoqiang Tang, Yanglingxi Wang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 5

Mild cognitive impairment in Parkinson's disease: current view
K. A. Jellinger
Frontiers in Cognition (2024) Vol. 3
Open Access | Times Cited: 4

Assessment tools for cognitive performance in Parkinson’s disease and its genetic contributors
LingXiao Cao, Wee Lee Kong, Piu Chan, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 4

Associations between frailty and cognitive impairment in Parkinson´s disease: a cross-sectional study
M. C. Sousa-Fraguas, Gustavo Rodríguez Fuentes, D. Lastra-Barreira, et al.
Aging Clinical and Experimental Research (2025) Vol. 37, Iss. 1
Open Access

Managing cognitive impairment in Parkinson’s disease: an update of the literature
Jennifer G. Goldman, Priya Jagota, Elie Matar
Expert Review of Neurotherapeutics (2025), pp. 1-21
Closed Access

Plasma alpha-synuclein predicts cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis
Ziyue Zhu, Dennis Cordato, Renfen Chen, et al.
Journal of Neurology (2025) Vol. 272, Iss. 2
Closed Access

Differences and contributors to global cognitive performance in the underrepresented Latinx Parkinson’s disease population
Saar Anis, Henry Mauricio Chaparro-Solano, Thiago Peixoto Leal, et al.
The Clinical Neuropsychologist (2025), pp. 1-21
Closed Access

Cepstral Changes Following Intensive Voice-Focused Treatment in Parkinson's Disease
Jonathan Delgado Hernández, Gemma Moya‐Galé
Journal of Voice (2025)
Closed Access

Drug-induced dementia: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
Lisi Xu, Ruonan Zhang, Xiaolin Zhang, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access

Regression-based thresholds to detect clinical changes in verbal fluency after STN-DBS in Parkinson’s disease.
Francesca Mameli, Edoardo Nicolò Aiello, Fabiana Ruggiero, et al.
Parkinsonism & Related Disorders (2025) Vol. 132, pp. 107300-107300
Closed Access

Neuropsychological review of records in forensic cases: An AACN best practices paper with international perspectives
Michael D. Chafetz, Jerry J. Sweet, Kyle B. Boone, et al.
The Clinical Neuropsychologist (2025), pp. 1-31
Closed Access

Language Dysfunction as a Primary Feature of Cognitive Decline in Neurological Populations
Victoria M. Leavitt, Leila Simani, Mahnaz Bayat, et al.
(2025)
Closed Access

Glymphatic dysfunction exacerbates cognitive decline by triggering cortical degeneration in Parkinson's disease: evidence from diffusion-tensor MRI.
Yang Zhao, Changyuan Xu, Yufan Chen, et al.
PubMed (2025) Vol. 7, Iss. 1, pp. fcaf029-fcaf029
Closed Access

A network perspective on cognition in individuals with Parkinson's disease
Daniel Scharfenberg, Elke Kalbe, Monika Balzer‐Geldsetzer, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2025) Vol. 17, Iss. 1
Open Access

Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline
J. Muñoz, Saül Martínez‐Horta, Arnau Puig‐Davi, et al.
Journal of Neurology (2025) Vol. 272, Iss. 3
Open Access

Scroll to top